ArticleFrontiers in immunology2026

Exploratory analysis of prognostic factors and hematologic dynamics in unresectable ESCC treated with concurrent versus interval immune checkpoint inhibitors combined with (chemo)radiotherapy: a multicenter real-world study.

Xiaohan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.